Intellectual Property, COVID-19, and the Next Pandemic - Title page

pp iii-iii

Copyright page

pp iv-iv

Contents

pp v-vi

Contributors

pp vii-viii

Introduction

pp 1-36

Part I - Reconsidering Key Theoretical and Policy Issues

pp 37-132

1 - New and Heightened Public–Private Quid Pro Quos

pp 39-62

2 - Global Medical War Chest

pp 63-85

3 - COVID-19 and Boundary-Crossing Collaboration

pp 86-105

4 - Legal Paradigms and the Politics of Global COVID-19 Vaccine Access

pp 106-132

Part II - Boosting Low-Income Countries’ Capacities for Protecting Public Health

pp 133-240

5 - Fostering Production of Pharmaceutical Products in Developing Countries

pp 135-167

6 - Patent Philanthropy

pp 168-194

7 - Beyond Traditional IP

pp 195-216

8 - Capability Approach to Developing Global Health Initiatives for Equitable Access to Vaccines

pp 217-240

Part III - Alternative Means of Fighting Pandemics

pp 241-340

9 - Planning for Pandemic and Epidemic-Related Scarcity of Medicines

pp 243-254

10 - Improving Global Governance of Pandemic Response

pp 255-286

11 - Compelling Trade Secret Sharing

pp 287-314

12 - Voluntary Intellectual Property Pledges and COVID-19

pp 315-340

Part IV - Toward Dynamic Protection of Public Health in China, Africa, and Latin America

pp 341-342

13 - China, the TRIPS Waiver, and the Global Pandemic Response

pp 343-363

14 - COVID-19 Exclusion, Policy Contagion, and Colonial Hangover in Africa

pp 364-381

15 - Technology Transfer for Production of COVID-19 Vaccines in Latin America

pp 382-412